• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酸腺苷依赖性蛋白激酶增强SC35促进的Tau外显子10包含。

Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.

作者信息

Chen Caoyi, Jin Nana, Qian Wei, Liu Wen, Tan Xiangling, Ding Fei, Gu Xiaosong, Iqbal Khalid, Gong Cheng-Xin, Zuo Ji, Liu Fei

机构信息

Department of Cellular and Genetic Medicine, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

出版信息

Mol Neurobiol. 2014 Feb;49(1):615-24. doi: 10.1007/s12035-013-8542-3. Epub 2013 Sep 14.

DOI:10.1007/s12035-013-8542-3
PMID:24037441
Abstract

Alternative splicing of tau exon 10 generates tau with three or four microtubule-binding repeats (3R-tau or 4R-tau). The ratio of 3R-tau to 4R-tau is approximately 1:1 in the adult normal human brain. Disturbances in the ratio result in neurodegenerative tauopathies. Splicing factor SC35 acts on a SC35-like element located at the 5' end of tau exon 10 and promotes tau exon 10 inclusion. Here, we report that protein kinase (PKA) was able to interact and phosphorylate SC35. Activation or overexpression of PKA catalytic subunits promoted SC35-mediated tau exon 10 inclusion. Four PKA catalytic subunits, α1, α2, β1, and β2, all enhanced SC35-promoted tau exon 10 inclusion. SC35 has four putative PKA phosphorylation sites, Ser121, Ser128, Ser130, and Ser171. Pseudophosphorylation (SC354E) and blockage (SC354A) of phosphorylation of SC35 at these four sites increased and decreased, respectively, SC35's ability to promote tau exon 10 inclusion. Moreover, PKA catalytic subunits no longer further enhanced tau exon 10 inclusion when these four were mutated to either alanine or glutamate. These results suggest that PKA interacts with and phosphorylates SC35 and enhances SC35-promoted tau exon 10 inclusion. In Alzheimer's brain, down-regulation of the PKA pathway could lead to dysregulation of tau exon 10, contributing to tau pathogenesis.

摘要

tau外显子10的可变剪接产生具有三个或四个微管结合重复序列的tau蛋白(3R-tau或4R-tau)。在成人人脑中,3R-tau与4R-tau的比例约为1:1。该比例的紊乱会导致神经退行性tau蛋白病。剪接因子SC35作用于位于tau外显子10 5'端的SC35样元件,并促进tau外显子10的包含。在此,我们报告蛋白激酶(PKA)能够与SC35相互作用并使其磷酸化。PKA催化亚基的激活或过表达促进了SC35介导的tau外显子l0的包含。四个PKA催化亚基α1、α2、β1和β2均增强了SC35促进的tau外显子10的包含。SC35有四个假定的PKA磷酸化位点,即Ser121、Ser128、Ser130和Ser171。SC35在这四个位点的假磷酸化(SC354E)和磷酸化阻断(SC354A)分别增加和降低了SC35促进tau外显子10包含的能力。此外,当这四个位点突变为丙氨酸或谷氨酸时,PKA催化亚基不再进一步增强tau外显子10的包含。这些结果表明,PKA与SC35相互作用并使其磷酸化,增强了SC35促进的tau外显子10的包含。在阿尔茨海默病大脑中,PKA途径的下调可能导致tau外显子10的失调,促进tau蛋白病的发生。

相似文献

1
Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.环磷酸腺苷依赖性蛋白激酶增强SC35促进的Tau外显子10包含。
Mol Neurobiol. 2014 Feb;49(1):615-24. doi: 10.1007/s12035-013-8542-3. Epub 2013 Sep 14.
2
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.SC35 和 Dyrk1A 对 tau 外显子 10 可变剪接的调控。
Nucleic Acids Res. 2011 Aug;39(14):6161-71. doi: 10.1093/nar/gkr195. Epub 2011 Apr 5.
3
SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.SIRT1 去乙酰化 SC35 并抑制其在 Tau 外显子 10 剪接中的功能。
J Alzheimers Dis. 2018;61(2):561-570. doi: 10.3233/JAD-170418.
4
Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10.环腺苷酸依赖的蛋白激酶调节 9G8 介导的 tau 外显子 10 的选择性剪接。
FEBS Lett. 2012 Jul 30;586(16):2239-44. doi: 10.1016/j.febslet.2012.05.046. Epub 2012 Jun 4.
5
HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.HIV-1反式激活蛋白通过上调双重特异性酪氨酸磷酸化调节激酶1A抑制SC35介导的Tau外显子10包含。
J Biol Chem. 2015 Dec 25;290(52):30931-46. doi: 10.1074/jbc.M115.675751. Epub 2015 Nov 3.
6
Splicing factor SC35 promotes tau expression through stabilization of its mRNA.剪接因子 SC35 通过稳定其 mRNA 促进 tau 表达。
FEBS Lett. 2011 Mar 23;585(6):875-80. doi: 10.1016/j.febslet.2011.02.017. Epub 2011 Feb 17.
7
Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.环腺苷酸依赖的蛋白激酶调节 tau 外显子 10 的选择性剪接:阿尔茨海默病 tau 病理相关的一种机制。
J Biol Chem. 2011 Apr 22;286(16):14639-48. doi: 10.1074/jbc.M110.204453. Epub 2011 Mar 2.
8
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.双特异性酪氨酸磷酸化调节激酶 1A(Dyrk1A)调节丝氨酸/精氨酸丰富蛋白 55(SRp55)促进 Tau 外显子 10 包含。
J Biol Chem. 2012 Aug 31;287(36):30497-506. doi: 10.1074/jbc.M112.355412. Epub 2012 Jul 5.
9
Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway.淀粉样β肽通过 GSK3β-SC35 通路改变 tau 外显子 10 的剪接。
Neurobiol Dis. 2010 Nov;40(2):378-85. doi: 10.1016/j.nbd.2010.06.013. Epub 2010 Jul 6.
10
Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.糖原合酶激酶-3在tau外显子10剪接及SC35的核内分布中起关键作用。对阿尔茨海默病的启示。
J Biol Chem. 2004 Jan 30;279(5):3801-6. doi: 10.1074/jbc.M311512200. Epub 2003 Nov 5.

引用本文的文献

1
Diverse influences on tau aggregation and implications for disease progression.tau蛋白聚集的多种影响因素及其对疾病进展的意义。
Genes Dev. 2025 May 2;39(9-10):555-581. doi: 10.1101/gad.352551.124.
2
Regulatory interplay between SR proteins governs kinase splice variants production.SR 蛋白之间的调控相互作用控制激酶剪接变体的产生。
RNA. 2024 Nov 18;30(12):1596-1607. doi: 10.1261/rna.080107.124.
3
The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.六种脑特异性 TAU 异构体及其在阿尔茨海默病及相关神经退行性痴呆综合征中的作用。

本文引用的文献

1
Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.四聚体向三聚体 tau 异构体的转变是神经原纤维病理树突和区域性进展的基础。
Acta Neuropathol. 2013 Apr;125(4):565-79. doi: 10.1007/s00401-013-1097-6. Epub 2013 Feb 14.
2
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.SC35 和 Dyrk1A 对 tau 外显子 10 可变剪接的调控。
Nucleic Acids Res. 2011 Aug;39(14):6161-71. doi: 10.1093/nar/gkr195. Epub 2011 Apr 5.
3
Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.
Alzheimers Dement. 2024 May;20(5):3606-3628. doi: 10.1002/alz.13784. Epub 2024 Mar 31.
4
Towards understandings of serine/arginine-rich splicing factors.迈向对富含丝氨酸/精氨酸剪接因子的理解。
Acta Pharm Sin B. 2023 Aug;13(8):3181-3207. doi: 10.1016/j.apsb.2023.05.022. Epub 2023 May 23.
5
Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease.寡聚化、磷酸化和截断的 tau 以及剪接体病理学在阿尔茨海默病各阶段的内嗅-海马连接组内。
J Comp Neurol. 2023 Dec;531(18):2080-2108. doi: 10.1002/cne.25466. Epub 2023 Mar 29.
6
Splicing factor SRSF2-centric gene regulation.剪接因子 SRSF2 为中心的基因调控。
Int J Biol Sci. 2021 Apr 16;17(7):1708-1715. doi: 10.7150/ijbs.58888. eCollection 2021.
7
Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.Delta 分泌酶(AEP)介导 tau 剪接失衡,并加速 tau 病的认知衰退。
J Exp Med. 2018 Dec 3;215(12):3038-3056. doi: 10.1084/jem.20180539. Epub 2018 Oct 29.
8
Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review.蛋白激酶A与焦虑相关行为:一篇综述短文
Front Endocrinol (Lausanne). 2016 Jun 29;7:83. doi: 10.3389/fendo.2016.00083. eCollection 2016.
9
Tau mis-splicing in the pathogenesis of neurodegenerative disorders.tau蛋白异常剪接在神经退行性疾病发病机制中的作用
BMB Rep. 2016 Aug;49(8):405-13. doi: 10.5483/bmbrep.2016.49.8.084.
10
Alternative Splicing in Alzheimer's Disease.阿尔茨海默病中的可变剪接
J Parkinsons Dis Alzheimers Dis. 2015 Aug;2(2). doi: 10.13188/2376-922X.1000010. Epub 2015 Aug 15.
环腺苷酸依赖的蛋白激酶调节 tau 外显子 10 的选择性剪接:阿尔茨海默病 tau 病理相关的一种机制。
J Biol Chem. 2011 Apr 22;286(16):14639-48. doi: 10.1074/jbc.M110.204453. Epub 2011 Mar 2.
4
Splicing factor SC35 promotes tau expression through stabilization of its mRNA.剪接因子 SC35 通过稳定其 mRNA 促进 tau 表达。
FEBS Lett. 2011 Mar 23;585(6):875-80. doi: 10.1016/j.febslet.2011.02.017. Epub 2011 Feb 17.
5
Effect of hypoxia and aging on PKC delta-mediated SC-35 phosphorylation in rat myocardial tissue.
Anat Rec (Hoboken). 2009 Aug;292(8):1135-42. doi: 10.1002/ar.20936.
6
Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons.Akt磷酸化的SRPK2与14-3-3的相互作用介导神经元的细胞周期和细胞死亡。
J Biol Chem. 2009 Sep 4;284(36):24512-25. doi: 10.1074/jbc.M109.026237. Epub 2009 Jul 10.
7
Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome.Dyrk1A剂量增加会改变唐氏综合征中替代剪接因子(ASF)调控的tau蛋白的替代剪接。
J Biol Chem. 2008 Oct 17;283(42):28660-9. doi: 10.1074/jbc.M802645200. Epub 2008 Jul 24.
8
Differential incorporation of tau isoforms in Alzheimer's disease.阿尔茨海默病中tau蛋白异构体的差异掺入
J Alzheimers Dis. 2008 May;14(1):1-16. doi: 10.3233/jad-2008-14101.
9
Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation.tau蛋白磷酸化对其微管组装活性和自我聚集的位点特异性影响。
Eur J Neurosci. 2007 Dec;26(12):3429-36. doi: 10.1111/j.1460-9568.2007.05955.x. Epub 2007 Dec 4.
10
Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.通过环磷酸腺苷(cAMP)和cAMP依赖性蛋白激酶的信号传导:药物设计的多种策略
Biochim Biophys Acta. 2008 Jan;1784(1):16-26. doi: 10.1016/j.bbapap.2007.10.002. Epub 2007 Oct 12.